Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma.
Régis T
RT
Costello
Corinne
C
Brunet
Françoise
F
Dignat-George
José
J
Sampol
Daniel
D
Olive
Jean-Albert
JA
Gastaut
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000187:drug effects; D014750:Vincristine / Q000008:administration & dosage
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D003561:Cytarabine; D019259:Lamivudine; D014750:Vincristine; D019469:Indinavir; D003520:Cyclophosphamide; D018119:Stavudine; D011241:Prednisone; D008727:Methotrexate